Immunology of COVID-19: Current State of the ScienceNicolas Vabret, Pauline Hamon, Graham J. Britton et al.|Immunity|2020Cited by 1.8k
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF InhibitionHélène Salmon, Miriam Mérad, Juliana Idoyaga et al.|Immunity|2016Cited by 1.2k
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Michael Alvarado et al.|Nature Medicine|2018Cited by 1k
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast CancerSylvia Adams, Sandra Demaria, Lina Kozhaya et al.|Clinical Cancer Research|2012Cited by 225